DESTIN, Fla. — More than 100 fellows and junior faculty members flocked to the 2019 North American Young Rheumatology Investigator Forum, where they presented research in oral and poster sessions.
The forum, now in its 13th year, gives attendees the floor to present their research and findings, and to receive critique and feedback from a panel of experienced rheumatologists.
“Today we’ve had just a wonderful occasion where we gather a group of mostly fellows and some internal medicine residents, and even some students, where they are all here united in their desire to talk about rheumatology, to share data that they have generated in their own research, and to hear from others who are in that same situation,” Ronald van Vollenhoven, MD, a professor at the Amsterdam University Medical Center and moderator of the forum, told Healio Rheumatology.
“We have a panel of international experts, mostly from the United States in North American but also a few Europeans, like me, and we discussed all kinds of topics, from the kinds of research you want to be doing from the early stage of your career,” he added. “Also, how you can integrate research into clinical practice situations, how you work with the clinical research and basic research, how you can interact with industry, how you choose your career goals, and in the end, what kind of rheumatologist you want to be.”
The forum included oral presentations of the top 11 abstracts. In addition, the expert panel awarded prizes to those they judged to be the top four posters and best three oral presentations. Prizes included cash and an iPad.
The top four poster presentations, as awarded by the judges were:
- “Extensive SVC thrombosis and IVC stenosis without thrombosis leading to Budd Chiari physiology in a patient without oral ulcers: An unusual presentation of Behçet’s disease,” presented by Sneha Sundaram, MD, of the University of Pennsylvania Medical Center;
- “Efficacy of infliximab in chronic inflammatory arthritis following parvovirus B19 infection,” presented by Kimberly Staudt, MD, of the Walter Reed Military Medical Center;
- “Organic anion transport inhibitors suppress chondrocyte pyrophosphate production,” presented by Mohammed S. Faseehuddin, DO, of the Medical College of Wisconsin; and
- “Felty’s syndrome’s conundrum: Large granular lymphocytic leukemia,” presented by Jonathan Aun, DO, of the Keesler Medical Center.
The top three oral presentations, as awarded by the expert panel, were:
Disclosure: van Vollenhoven reports no relevant financial disclosures.